Provided by Tiger Fintech (Singapore) Pte. Ltd.

Addus HomeCare

100.31
-1.0200-1.01%
Pre-market: 98.81-1.5000-1.50%04:31 EDT
Volume:421.15K
Turnover:42.22M
Market Cap:1.80B
PE:23.71
High:101.51
Open:99.68
Low:97.84
Close:101.33
Loading ...

RBC Trims Price Target on Addus HomeCare to $133 From $136, Keeps Outperform Rating

MT Newswires Live
·
28 Feb

Addus HomeCare’s Earnings Call Highlights Growth and Strategic Moves

TIPRANKS
·
28 Feb

Addus HomeCare Is Maintained at Outperform by Macquarie

Dow Jones
·
28 Feb

U.S. RESEARCH ROUNDUP-Abbvie, Freeport-McMoran, Goldman Sachs

Reuters
·
27 Feb

Addus Homecare Corp : TD Cowen Cuts Target Price to $135 From $141

THOMSON REUTERS
·
27 Feb

BUZZ-U.S. STOCKS ON THE MOVE-Cheesecake Factory, SiriusPoint, Arcutis Biosciences

Reuters
·
27 Feb

Addus HomeCare Is Maintained at Overweight by Stephens & Co.

Dow Jones
·
26 Feb

BUZZ-Stephens lowers PT for Addus HomeCare amid Medicaid funding uncertainity

Reuters
·
26 Feb

Addus HomeCare Corporation (NASDAQ:ADUS) Just Released Its Yearly Results And Analysts Are Updating Their Estimates

Simply Wall St.
·
26 Feb

Addus Homecare Corp : Stephens Cuts Target Price to $142 From $153

THOMSON REUTERS
·
26 Feb

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Addus Homecare (ADUS) and Beam Therapeutics (BEAM)

TIPRANKS
·
26 Feb

KeyBanc Reaffirms Their Buy Rating on Addus Homecare (ADUS)

TIPRANKS
·
26 Feb

Q4 2024 Addus Homecare Corp Earnings Call

Thomson Reuters StreetEvents
·
26 Feb

Addus HomeCare Corp (ADUS) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and ...

GuruFocus.com
·
26 Feb

Addus HomeCare Down Nearly 11%, on Pace for Largest Percent Decrease Since April 2023 -- Data Talk

Dow Jones
·
26 Feb

RBC Capital buyers of Addus HomeCare shares amid weakness

TIPRANKS
·
26 Feb

Addus HomeCare to Participate in TD Cowen 45th Annual Health Care Conference

Business Wire
·
26 Feb

TD Cowen Sticks to Their Buy Rating for Addus Homecare (ADUS)

TIPRANKS
·
25 Feb

Addus HomeCare: Strong Financial Performance and Growth Potential Justify Buy Rating

TIPRANKS
·
25 Feb

Analysts Have Conflicting Sentiments on These Healthcare Companies: BioCryst (BCRX), Addus Homecare (ADUS) and Jazz Pharmaceuticals (JAZZ)

TIPRANKS
·
25 Feb